The HTA has funded the PART Trial - A randomised controlled trial of Partial prostate Ablation versus Radical prosTatectomy (PART) in intermediate risk, unilateral clinically localised prostate cancer. Work on the trial officially started on 1st January 2015, further information on the trial and its progress will be available soon on the OCTRU Current Projects Page.
